Fabian Byvald

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Combination Therapy

Induced Apoptosis

Immune Response

Locally Advanced

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Azar Rezapour, Daniel Rydbeck, Fabian Byvald, Viktor Tasselius, Gustaf Danielsson, Eva Haglind, Ulf Yrlid
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8 + T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma. Oncoimmunology 12 (1) (2023)
Azar Rezapour, Daniel Rydbeck, Fabian Byvald, Viktor Tasselius, Gustaf Danielsson, Eva Haglind, Ulf Yrlid
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8 + T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma. Oncoimmunology 12 (1) (2023)
Frank Liang, Lisa M Nilsson, Fabian Byvald, Azar Rezapour, Helena Taflin, Jonas Andreas Nilsson, Ulf Yrlid
A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T Cells. Cancers 14 (12) (2022)